Cargando…

Antibiotic prescription strategies and adverse outcome for uncomplicated lower respiratory tract infections: prospective cough complication cohort (3C) study

Objective To assess the impact on adverse outcomes of different antibiotic prescribing strategies for lower respiratory tract infections in people aged 16 years or more. Design Prospective cohort study. Setting UK general practice. Participants 28 883 patients with lower respiratory tract infection;...

Descripción completa

Detalles Bibliográficos
Autores principales: Little, Paul, Stuart, Beth, Smith, Sue, Thompson, Matthew J, Knox, Kyle, van den Bruel, Ann, Lown, Mark, Moore, Michael, Mant, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439222/
https://www.ncbi.nlm.nih.gov/pubmed/28533265
http://dx.doi.org/10.1136/bmj.j2148
_version_ 1783237906284937216
author Little, Paul
Stuart, Beth
Smith, Sue
Thompson, Matthew J
Knox, Kyle
van den Bruel, Ann
Lown, Mark
Moore, Michael
Mant, David
author_facet Little, Paul
Stuart, Beth
Smith, Sue
Thompson, Matthew J
Knox, Kyle
van den Bruel, Ann
Lown, Mark
Moore, Michael
Mant, David
author_sort Little, Paul
collection PubMed
description Objective To assess the impact on adverse outcomes of different antibiotic prescribing strategies for lower respiratory tract infections in people aged 16 years or more. Design Prospective cohort study. Setting UK general practice. Participants 28 883 patients with lower respiratory tract infection; symptoms, signs, and antibiotic prescribing strategies were recorded at the index consultation. Main outcome measures The main outcomes were reconsultation with symptoms of lower respiratory tract infection in the 30 days after the index consultation, hospital admission, or death. Multivariable analysis controlled for an extensive list of variables related to the propensity to prescribe antibiotics and for clustering by doctor. Results Of the 28 883 participants, 104 (0.4%) were referred to hospital for radiographic investigation or admission, or both on the day of the index consultation, or were admitted with cancer. Of the remaining 28 779, subsequent hospital admission or death occurred in 26/7332 (0.3%) after no antibiotic prescription, 156/17 628 (0.9%) after prescription for immediate antibiotics, and 14/3819 (0.4%) after a prescription for delayed antibiotics. Multivariable analysis documented no reduction in hospital admission and death after immediate antibiotics (multivariable risk ratio 1.06, 95% confidence interval 0.63 to 1.81, P=0.84) and a non-significant reduction with delayed antibiotics (0.81, 0.41 to 1.64, P=0.61). Reconsultation for new, worsening, or non-resolving symptoms was common (1443/7332 (19.7%), 4455/17 628 (25.3%), and 538/3819 (14.1%), respectively) and was significantly reduced by delayed antibiotics (multivariable risk ratio 0.64, 0.57 to 0.72, P<0.001) but not by immediate antibiotics (0.98, 0.90 to 1.07, P=0.66). Conclusion Prescribing immediate antibiotics may not reduce subsequent hospital admission or death for young people and adults with uncomplicated lower respiratory tract infection, and such events are uncommon. If clinicians are considering antibiotics, a delayed prescription may be preferable since it is associated with a reduced number of reconsultations for worsening illness.
format Online
Article
Text
id pubmed-5439222
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group Ltd.
record_format MEDLINE/PubMed
spelling pubmed-54392222017-05-26 Antibiotic prescription strategies and adverse outcome for uncomplicated lower respiratory tract infections: prospective cough complication cohort (3C) study Little, Paul Stuart, Beth Smith, Sue Thompson, Matthew J Knox, Kyle van den Bruel, Ann Lown, Mark Moore, Michael Mant, David BMJ Research Objective To assess the impact on adverse outcomes of different antibiotic prescribing strategies for lower respiratory tract infections in people aged 16 years or more. Design Prospective cohort study. Setting UK general practice. Participants 28 883 patients with lower respiratory tract infection; symptoms, signs, and antibiotic prescribing strategies were recorded at the index consultation. Main outcome measures The main outcomes were reconsultation with symptoms of lower respiratory tract infection in the 30 days after the index consultation, hospital admission, or death. Multivariable analysis controlled for an extensive list of variables related to the propensity to prescribe antibiotics and for clustering by doctor. Results Of the 28 883 participants, 104 (0.4%) were referred to hospital for radiographic investigation or admission, or both on the day of the index consultation, or were admitted with cancer. Of the remaining 28 779, subsequent hospital admission or death occurred in 26/7332 (0.3%) after no antibiotic prescription, 156/17 628 (0.9%) after prescription for immediate antibiotics, and 14/3819 (0.4%) after a prescription for delayed antibiotics. Multivariable analysis documented no reduction in hospital admission and death after immediate antibiotics (multivariable risk ratio 1.06, 95% confidence interval 0.63 to 1.81, P=0.84) and a non-significant reduction with delayed antibiotics (0.81, 0.41 to 1.64, P=0.61). Reconsultation for new, worsening, or non-resolving symptoms was common (1443/7332 (19.7%), 4455/17 628 (25.3%), and 538/3819 (14.1%), respectively) and was significantly reduced by delayed antibiotics (multivariable risk ratio 0.64, 0.57 to 0.72, P<0.001) but not by immediate antibiotics (0.98, 0.90 to 1.07, P=0.66). Conclusion Prescribing immediate antibiotics may not reduce subsequent hospital admission or death for young people and adults with uncomplicated lower respiratory tract infection, and such events are uncommon. If clinicians are considering antibiotics, a delayed prescription may be preferable since it is associated with a reduced number of reconsultations for worsening illness. BMJ Publishing Group Ltd. 2017-05-23 /pmc/articles/PMC5439222/ /pubmed/28533265 http://dx.doi.org/10.1136/bmj.j2148 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/.
spellingShingle Research
Little, Paul
Stuart, Beth
Smith, Sue
Thompson, Matthew J
Knox, Kyle
van den Bruel, Ann
Lown, Mark
Moore, Michael
Mant, David
Antibiotic prescription strategies and adverse outcome for uncomplicated lower respiratory tract infections: prospective cough complication cohort (3C) study
title Antibiotic prescription strategies and adverse outcome for uncomplicated lower respiratory tract infections: prospective cough complication cohort (3C) study
title_full Antibiotic prescription strategies and adverse outcome for uncomplicated lower respiratory tract infections: prospective cough complication cohort (3C) study
title_fullStr Antibiotic prescription strategies and adverse outcome for uncomplicated lower respiratory tract infections: prospective cough complication cohort (3C) study
title_full_unstemmed Antibiotic prescription strategies and adverse outcome for uncomplicated lower respiratory tract infections: prospective cough complication cohort (3C) study
title_short Antibiotic prescription strategies and adverse outcome for uncomplicated lower respiratory tract infections: prospective cough complication cohort (3C) study
title_sort antibiotic prescription strategies and adverse outcome for uncomplicated lower respiratory tract infections: prospective cough complication cohort (3c) study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439222/
https://www.ncbi.nlm.nih.gov/pubmed/28533265
http://dx.doi.org/10.1136/bmj.j2148
work_keys_str_mv AT littlepaul antibioticprescriptionstrategiesandadverseoutcomeforuncomplicatedlowerrespiratorytractinfectionsprospectivecoughcomplicationcohort3cstudy
AT stuartbeth antibioticprescriptionstrategiesandadverseoutcomeforuncomplicatedlowerrespiratorytractinfectionsprospectivecoughcomplicationcohort3cstudy
AT smithsue antibioticprescriptionstrategiesandadverseoutcomeforuncomplicatedlowerrespiratorytractinfectionsprospectivecoughcomplicationcohort3cstudy
AT thompsonmatthewj antibioticprescriptionstrategiesandadverseoutcomeforuncomplicatedlowerrespiratorytractinfectionsprospectivecoughcomplicationcohort3cstudy
AT knoxkyle antibioticprescriptionstrategiesandadverseoutcomeforuncomplicatedlowerrespiratorytractinfectionsprospectivecoughcomplicationcohort3cstudy
AT vandenbruelann antibioticprescriptionstrategiesandadverseoutcomeforuncomplicatedlowerrespiratorytractinfectionsprospectivecoughcomplicationcohort3cstudy
AT lownmark antibioticprescriptionstrategiesandadverseoutcomeforuncomplicatedlowerrespiratorytractinfectionsprospectivecoughcomplicationcohort3cstudy
AT mooremichael antibioticprescriptionstrategiesandadverseoutcomeforuncomplicatedlowerrespiratorytractinfectionsprospectivecoughcomplicationcohort3cstudy
AT mantdavid antibioticprescriptionstrategiesandadverseoutcomeforuncomplicatedlowerrespiratorytractinfectionsprospectivecoughcomplicationcohort3cstudy